Investigator
Associate Professor in Pharmacology and Neuropharmacology · University of L'Aquila
Probiotics as Anti-Tumor Agents: Insights from Female Tumor Cell Culture Studies
Breast and ovarian cancers are among the most prevalent cancers in women. Cancerous cells are characterized by their ability to continuously cycle and migrate, forming metastases. Some probiotic strains have shown anti-tumorigenic effects. This study tested the impact of probiotics on OVCAR-3 and MDA-MB-231 cell lines by analyzing proteins involved in cell cycle regulation (pP53, Cyclin D1, pERK1), cell survival (AKT), and cell migration (RhoA) using Western blotting and scratch wound tests. Results indicated a reduction in these proteins and decreased cell migration velocity post-treatment. These findings suggest that certain probiotic combinations can arrest the cell cycle, promote cell death, and reduce cell migration, potentially serving as promising candidates alongside standard therapies.
Associate Professor in Pharmacology and Neuropharmacology
University of L'Aquila
Post-doc Researcher
Università degli Studi dell'Aquila Dipartimento di Medicina Clinica Sanità Pubblica Scienze della Vita e dell'Ambiente · MESVA
PhD student
University of L'Aquila · department of life, health and environmental sciences
Research Scholar
University of South Florida · Neurosurgery and Brain Repair
PhD
Università degli Studi dell'Aquila · MESVA
Visiting Phd researcher
University of Tampa
Visiting research
University of Birmingham · cancer science
IT
Scopus: 57208243848
Researcher Id: AAH-6787-2020